drugset / Trial / NCT06312813

Evaluating Use of Topical Imipramine and Amitriptyline in Reducing Ultraviolet B Light-Induced Redness in Patients With Rosacea

NCT06312813

Phase 2 Recruiting 48 enrolled Wright State University
RandomizedParallel-groupDouble-blindTreatment

Summary

Rosacea is a common skin condition associated with easy blushing and red face; many patients with rosacea react to sunlight with increased redness. The purpose of this study is to determine if the use of a topical medication will help reduce sunlight induced redness and irritation in patients with rosacea.

Timeline

Start
2024-02-27
Primary completion
2028-12-01
Completion
2028-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Amitriptyline Small molecule 4 % Topical
Subject Imipramine Small molecule 4 % Topical

Indications